Showing results (61-70 of 214) with videos related to
Sort By:
Pageof 22
Medicine|January 29, 2016
Using a Harmonic Scalpel "Drilling and Clamping" Method to Implement Zero Ischemic Robotic-assisted Partial Nephrectomy: An Observation Case Report StudyChen-Pang Hou, Yu-Hsiang Lin, Yu-Chao Hsu, et al.Clinical Interventions in Aging|December 15, 2025
Comparative Analysis of Enucleation Techniques for Large Benign Prostatic Hyperplasia (>80 cm<sup>3</sup>) in Older Adult Patients: A Single-Center Cohort StudyChen Pang Hou, Yu-Ting Chen, Yu-Hsiang Lin, et al.Reproductive Sciences (Thousand Oaks, Calif.)|February 7, 2018
Association Between Genetic Polymorphisms of WNT1 Inducible Signaling Pathway Protein 1 and Uterine Cervical CancerYu-Hsiang Lin, Yi-Hsuan Hsiao, Shun-Fa Yang, et al.Cancers|December 22, 2019
Maspin is a PTEN-Upregulated and p53-Upregulated Tumor Suppressor Gene and Acts as an HDAC1 Inhibitor in Human Bladder CancerYu-Hsiang Lin, Ke-Hung Tsui, Kang-Shuo Chang, et al.Cancer Medicine|December 15, 2017
BTG2 is a tumor suppressor gene upregulated by p53 and PTEN in human bladder carcinoma cellsKe-Hung Tsui, Kun-Chun Chiang, Yu-Hsiang Lin, et al.Colloids and Surfaces. B, Biointerfaces|October 23, 2017
Microemulsion formulation design and evaluation for hydrophobic compound: Catechin topical applicationYu-Hsiang Lin, Ming-Jun Tsai, Yi-Ping Fang, et al.Cancers|October 5, 2019
Migration and Invasion Enhancer 1 Is an NF-ĸB-Inducing Gene Enhancing the Cell Proliferation and Invasion Ability of Human Prostate Carcinoma Cells In Vitro and In VivoKang-Shuo Chang, Ke-Hung Tsui, Yu-Hsiang Lin, et al.Oncotargets and Therapy|June 28, 2017
Prognosis of prostate cancer with initial prostate-specific antigen >1,000 ng/mL at diagnosisHung-Cheng Kan, Chen-Pang Hou, Yu-Hsiang Lin, et al.Healthcare (Basel, Switzerland)|June 13, 2025
Associations Between Sleep Quality and Self-Reported Health Status in Middle-Aged and Older Adults: A Community-Based, Cross-Sectional Study in Northern TaiwanWen-Hsueh Chen, Chao-Tung Chen, Kai-Hung Cheng, et al.Journal of Translational Medicine|July 2, 2025
Baseline serum EV-miR-1-3p as a protective factor and biomarker for hepatocellular carcinoma development after HCV eradicationWei Teng, Wei-Ting Ku, Po-Ting Lin, et al.Pageof 22